The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Jozef Bartunek
Showing 1-11 of 11 articles
Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial
Pellicano M,
Di Gioia G,
Ciccarelli G,
Xaplanteris P,
Delrue L,
Toth G,
Van Durme F,
Heyse A,
Wyffels E,
Vanderheyden M,
Bartunek J,
De Bruyne B,
Barbato E
June 12, 2020 | 10.4244/EIJ-D-18-01138
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction
Paitazoglou C,
Özdemir R,
Pfister R,
Bergmann M,
Bartunek J,
Kilic T,
Lauten A,
Schmeisser A,
Zoghi M,
Anker S,
Sievert H,
Mahfoud F
August 29, 2019 | 10.4244/EIJ-D-19-00342
Plaque protrusion compromising bioresorbable coronary scaffold patency
Flore V,
Pellicano M,
Adjedj J,
Ferrara A,
Van Der Steen K,
Bartunek J
September 18, 2016 | 10.4244/EIJV12I7A142
Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study
Verheye S,
Khattab A,
Carrié D,
Stella P,
Slagboom T,
Bartunek J,
Onuma Y,
Serruys P
August 5, 2016 | 10.4244/EIJV12I5A101
Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function
Diserafino L,
Pyxaras S,
Mangiacapra F,
Dierickx K,
Toth G,
Bartunek J,
De Bruyne B,
van Mieghem C,
Wijns W,
Barbato E
March 22, 2013 | 10.4244/EIJV8I11A193
Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction
Mueller O,
Delrue L,
Hamilos M,
Vercauteren S,
Ntalianis A,
Trana C,
Mangiacapra F,
Dierickx K,
De Bruyne B,
Wijns W,
Behfar A,
Barbato E,
Terzic A,
Vanderheyden M,
Bartunek J
August 30, 2011 | 10.4244/EIJV7I4A75
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial
Duckers H,
Houtgraaf J,
Hehrlein C,
Schofer J,
Waltenberger J,
Gershlick A,
Bartunek J,
Nienaber C,
Naber C,
Macaya C,
Peters N,
Smits P,
Siminiak T,
van Mieghem W,
Legrand V,
Serruys P
February 21, 2011
Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis
Melikian N,
Vercauteren S,
Fearon W,
Cuisset T,
MacCarthy P,
Davidavicius G,
Aarnoudse W,
Bartunek J,
Vanderheyden M,
Wyffels E,
Wijns W,
Heyndrickx G,
Pijls NHJ,
De Bruyne B
April 12, 2010
The recurrence of iatrogenic femoral artery pseudoaneurysm after occlusion by ultrasound guided percutaneous thrombin injection
Madaric J,
Mistrik A,
Vulev I,
Liska B,
Vozar M,
Lederer P,
Gocar M,
Kozlovska T,
Fridrich V,
De Bruyne B,
Bartunek J
September 30, 2009
Bone marrow mesenchymal stem cells and cardiac regeneration
Bartunek J,
Hill J,
Behfar A,
Wijns W,
Vanderheyden M,
Willemsen P,
de Lavareille A,
Faber B,
Heyndrickx G,
Terzic A
May 22, 2007
Framework towards optimisation of bone marrow stem cells therapy for cardiac repair
Vanderheyden M,
Heyndrickx G,
Wijns W,
Bartunek J
May 22, 2007
1
Latest news
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
AHEAD OF PRINT
Antiplatelet therapy following PCI for stable CAD
FREE ARTICLE - Anoop N. Koshy et al
January 19, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke